Stocks and Investing Stocks and Investing
Thu, September 2, 2021
Wed, September 1, 2021
Tue, August 31, 2021
Mon, August 30, 2021
Fri, August 27, 2021
Thu, August 26, 2021

David Lebowitz Maintained (ASND) at Buy with Increased Target to $204 on, Aug 26th, 2021


Published on 2024-10-27 17:46:55 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $197 to $204 on, Aug 26th, 2021.

David has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $189 on, Monday, June 14th, 2021
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $196 on, Tuesday, June 1st, 2021